drugset / Trial / NCT00296127

Study of Celecoxib Bioavailability in Healthy Subjects

NCT00296127

Phase 1 Completed 24 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule

Timeline

Start
2006-02
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified

Indications

No indication recorded.